Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v2-FR
Language English French
Date Updated 2021-04-22 2021-01-05
Drug Identification Number 02265516 02265516
Brand name MYLAN-LAMOTRIGINE MYLAN-LAMOTRIGINE
Common or Proper name LAMOTRIGINE LAMOTRIGINE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients LAMOTRIGINE LAMOTRIGINE
Strength(s) 150MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BT 100BT
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2020-12-10 2020-12-10
Estimated end date 2021-04-20 2021-02-23
Actual end date 2021-04-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments